TAS-117 Terminated Phase 1 Trials for Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations / Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04770246TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations